Table 1.

Estimates of deaths and incidence and prevalence of metastatic cancer including de novo and recurrent metastatic disease in the United States for 2018^a

Cancer type	Number in US population in 2018	Number of cancer deaths		Number of new metastatic cancer cases (incidence)		Number of individuals living with metastatic disease on January 1, 2018 (prevalence)
		Observed	Estimated	De novo (observed)	De novo and recurrence (estimated)	De novo (observed)	De novo and recurrence (estimated)
Lung and bronchus	326 687 501	142 211	142 069	95 723	148 533	121 943	174 090
Breast (female)	165 801 767	39 974	40 029	15 800	46 666	54 117	140 230
Colon and rectum	326 687 501	48 154	47 857	32 015	55 162	74 784	133 234
Prostate (male)	160 885 734	26 172	25 881	18 469	40 388	54 207	120 368
Melanoma	326 687 501	7693	7586	3928	9468	11 979	39 716
Bladder	326 687 501	14 193	14 140	4070	15 874	4446	15 767

^aEstimates are presented for males and females together (all ages) unless otherwise specified.